Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4125 AUD | -8.33% | -6.25% | +19.57% |
06-03 | Immutep, Merck Collaborate on Trial for Lung Cancer Therapy | MT |
06-03 | Immutep, Merck Partner for Efti and Keytruda Combo in Lung Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.57% | 357M | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- IMM Stock
- News Immutep Limited
- Immutep Says Safety Lead-in Phase of Breast Cancer Study Yields 'Encouraging' Data